Literature DB >> 25870448

Ceftriaxone-induced immune hemolytic anemia.

G Neuman, S Boodhan, I Wurman.   

Abstract

Neuman, G, Boodhan, S, Wurman, I, et al. Ceftriaxone-induced immune hemolytic anemia. Ann Pharmacother. 2014;48:1594-1604. doi: 10.1177/1060028014548310. On page 1599 of the above article, lines 12-13 in the left column, there is a sentence which reads: "In the subgroup of children, 64% of the cases were fatal." This sentence should have read: "Sixty-four percent of these fatalities were children."
© The Author(s) 2015.

Entities:  

Year:  2015        PMID: 25870448     DOI: 10.1177/1060028015580345

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  2 in total

1.  Ceftriaxone-Induced Immune Hemolytic Anemia: In Vitro Reversal with Peptide Inhibitor of Complement C1 (PIC1).

Authors:  Kenji M Cunnion; Lisa M Feagin; Michael F Chicella; Cortney L Kaszowski; Pamela S Hair; Jessica Price; William C Owen
Journal:  Case Rep Hematol       Date:  2019-01-30

Review 2.  The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy.

Authors:  Neel K Krishna; Kenji M Cunnion; Grace A Parker
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.